Cytec Industries Inc. v Nalco Company

Link copied
Case Copied 26 min read

FEDERAL COURT OF AUSTRALIA

Cytec Industries Inc. v Nalco Company [2019] FCA 1800

File number(s): NSD 130 of 2019
Judge(s): BURLEY J
Date of judgment: 4 November 2019
Catchwords: PATENTS – application to amend under s 105(1A) of the Patents Act 1990 (Cth) – reducing aluminosilicate scale in the Bayer process – where amendments narrow the claims by specifying particular molecules to be used – application to amend granted
Legislation:

Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth)

Patents Act 1990 (Cth) ss 40, 60(4), 102, 104, 105(1A), 105(2), 112

Cases cited:

Bristol-Myers Squibb Company v Apotex Pty Ltd (No 2) [2010] FCA 901

Cytec Industries Inc. v Nalco Company [2018] APO 4

Cytec Industries Inc. v Nalco Company [2019] APO 2

Electronic Tax-Free Shopping Ltd v Fexco Merchant Services (No 3) [2017] FCA 569

Garford Pty Ltd v Dywidag-Systems International Pty Ltd [2014] FCA 1039

Idenix Pharmaceuticals LLC v Gilead Sciences Pty Ltd (No 2) [2018] FCAFC 7

Technological Resources Pty Limited v Tettman [2018] FCA 1770

Date of hearing: 30 October 2019
Registry: New South Wales
Division: General Division
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Category: Catchwords
Number of paragraphs: 51
Solicitor for the Appellant: Mr P Kerr of Allens
Counsel for the Respondent: Mr J S Cooke with Ms A E McDonald
Solicitor for the Respondent: Shelston IP

ORDERS

NSD 130 of 2019
BETWEEN:

CYTEC INDUSTRIES INC.

Appellant

AND:

NALCO COMPANY

Respondent

AND BETWEEN:

NALCO COMPANY

Cross-Appellant

AND:

CYTEC INDUSTRIES INC.

Cross-Respondent

JUDGE:

BURLEY J

DATE OF ORDER:

4 November 2019

THE COURT ORDERS THAT:

1.Pursuant to s 105(1A) of the Patents Act 1990 (Cth), the claims of Australian Patent Application No. 2012220990 be amended to take the form indicated in Annexure A to these orders.

2.The respondent pay the appellant’s costs of the respondent’s interlocutory application filed on 29 March 2019.

3.The proceedings be listed for case management on 21 November 2019.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

ANNEXURE A

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:-

1.A method for the reduction of aluminosilicate containing scale in a Bayer process comprising the step of:    

adding to the Bayer process stream an aluminosilicate scale inhibiting amount of a composition comprising at least one small molecule

selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX), (XXXII) through (XLVII), (LIII) through (LVIII) and (LX) within a product mixture formed from the reaction of a) hexane diamine, ethylene diamine or 1-amino-2-propanol; b) 3-glycidoxypropyltrimethoxysilane; and c) 2-ethylhexyl glycidyl ether: 

2.A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX) and (XXXII) through (XLII).

3.A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII) through (LVIII).

4.A method according to claim 1, wherein the small molecule is selected from the group consisting of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2019] FCA 1800
Decision Date

CaseChat Overview and Summary

Cytec Industries Inc. filed an application under section 105(1A) of the Patents Act 1990 (Cth) to amend Australian Patent Application No. 2012220990. The application related to a method for reducing aluminosilicate scale in the Bayer process. The proposed amendments narrowed the claims by specifying particular molecules to be used in the composition. Nalco Company opposed the application. The central legal issues revolved around whether the proposed amendments would narrow the scope of the patent claims in a manner consistent with section 105(1A) of the Patents Act and whether the amendments would introduce new matter.

The court found that the proposed amendments did indeed narrow the scope of the claims as required by section 105(1A) of the Patents Act. The court noted that the amendments specified particular molecules to be used in the composition, thereby narrowing the scope of the claims. The court also found that the amendments did not introduce new matter, as the proposed molecules were already disclosed in the original application. The court was satisfied that the amendments were consistent with the requirements of the Act and granted the application to amend the patent claims. The court also ordered that the respondent pay the appellant’s costs of the interlocutory application and listed the proceedings for case management.

Orders

Orders of the court

1. Pursuant to s 105(1A) of the Patents Act 1990 (Cth), the claims of Australian Patent Application No. 2012220990 be amended to take the form indicated in Annexure A to these orders.

2. The respondent pay the appellant’s costs of the respondent’s interlocutory application filed on 29 March 2019.

3. The proceedings be listed for case management on 21 November 2019.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

ANNEXURE A

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:-

1. A method for the reduction of aluminosilicate containing scale in a Bayer process comprising the step of:

adding to the Bayer process stream an aluminosilicate scale inhibiting amount of a composition comprising at least one small molecule

selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX), (XXXII) through (XLVII), (LIII) through (LVIII) and (LX) within a product mixture formed from the reaction of a) hexane diamine, ethylene diamine or 1-amino-2-propanol; b) 3-glycidoxypropyltrimethoxysilane; and c) 2-ethylhexyl glycidyl ether:

2. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX) and (XXXII) through (XLII).

3. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII) through (LVIII).

4. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII), (LIV) and (LV).

5. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (IX).

6. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (X) through (XIII) and (XV) through (XIX).

7. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XX) through (XXII).

8. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXIII) through (XXIX).

9. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXX) and (XXXII).

10. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXXIII) though (XLII).

11. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LVI) through (LVIII) and (LX).

12. A method according to claim 1, wherein the small molecule is present in a solution in an amount ranging from about 0.01 to about 100 wt%.

13. A method according to claim 1, wherein the composition further comprises an item selected from the list consisting of: amines, activators, antifoaming agents, co-absorbents, corrosion inhibitors, coloring agents, and any combination thereof.

14. A method according to claim 1, wherein the composition comprises a solvent, the solvent is selected from the group consisting of: water, alcohols, polyols, other industrial solvents, organic solvents, and any combination thereof.

15. A method according to claim 1, wherein the composition is isolated from a synthesis reaction in the form of a solid, precipitate, gel, salt and/or crystalline material in pHs ranging from 0 to 14.

16. A method according to claim 1, wherein the composition is hydrolyzed prior to being added to the Bayer process.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.